For a woman in Manila navigating a healthcare appointment, the process can be a fragmented ordeal. Hati Health, a startup founded in 2023, is trying to consolidate that journey into a single digital touchpoint. Its bet is that by first aggregating demand through a consumer-facing marketplace, it can then sell software back to the clinics serving those patients, creating a two-sided network anchored in women's health [Hati Health FAQ].
The Two-Sided Network Wedge
The company's initial wedge is its consumer marketplace, which lists over 100 partner clinics across the Philippines [Hati Health FAQ]. Through it, users can book appointments for services ranging from online consultations and lab tests to vaccines and curated care programs for conditions like PCOS. A 24/7 AI chat assistant, called Hati Bot, offers preliminary symptom advice [F6S]. The more strategic B2B play is a white-label AI suite offered to those same clinics. The software aims to optimize back-end operations like scheduling, payments, and patient management, theoretically increasing clinic efficiency and locking in Hati Health as a critical operational partner [F6S].
Early Validation and Regional Focus
Hati Health's early progress is marked by a regional award and seed funding. In June 2024, the company won the InsureTech Connect Asia Awards in Singapore [The Independent Investor, June 2024]. The startup has raised a pre-seed round of $500,000, with backing from regional investors Forge Ventures and Wavemaker Partners, as well as angel investor Ron Hose [The Independent Investor]. The founding team, led by CEO Maria Gaitanidou alongside Alex Gridnev and Aiai Garcia, is building from its headquarters in Metro Manila [SGPGrid].
The Path to Scale and Sustainability
For Hati Health, the next twelve months will test whether its two-sided model can achieve sustainable liquidity. Key milestones will involve moving beyond clinic listings to demonstrate that its AI tools are driving tangible operational savings for partners, which would justify the software's cost. The company must also prove it can move patients from one-off bookings into recurring, higher-value care programs.